Prosecution Insights
Last updated: May 29, 2026

Grail, Inc.

14 pending office actions • 5 art units • 10 examiners • 0 of 14 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Portfolio Summary

14
Total Pending OAs
6
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
2
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 7 days (2)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (50%)
4
Medium (29%)
0
Easy (0%)
3
Unknown (21%)

Rejection Statute Mix

BucketCases
§101 only7 (50%)
§103 only3 (21%)
§102 only1 (7%)
No statute on record3 (21%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

14
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SALMON, KATHERINE D 2 42.6% +38.0%
SCHLOOP, ALLISON ELIZABETH 2 61.8% +56.5%
KALLAL, ROBERT JAMES 2 58.1% +37.7%
HAYES, JONATHAN EDWARD 2 34.8% +22.8%
GUSSOW, ANNE 1 58.2% +43.0%
BUCHANAN, BAILEY CHEYENNE 1 50.0% +46.7%
AUGER, NOAH ANDREW 1 34.8% +37.7%
KRIANGCHAIVECH, KETTIP 1 20.8% +32.8%
MINCHELLA, KAITLYN L 1 27.1% +21.7%
SCHULTZHAUS, JANNA NICOLE 1 33.3% +40.2%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17144021 BITERMINAL DNA FRAGMENT TYPES IN CELL-FREE SAMPLES AND USES THEREOF HAYES, JONATHAN EDWARD 112d overdue
17105175 SYSTEMS AND METHODS FOR EVALUATING LONGITUDINAL BIOLOGICAL FEATURE DATA AUGER, NOAH ANDREW 104d overdue
16721619 CELL-FREE DNA END CHARACTERISTICS MINCHELLA, KAITLYN L 93d overdue
17047676 SYSTEMS AND METHODS FOR DETERMINING TUMOR FRACTION IN CELL-FREE NUCLEIC ACID HAYES, JONATHAN EDWARD 19d overdue
15931022 MODEL-BASED FEATURIZATION AND CLASSIFICATION KRIANGCHAIVECH, KETTIP 10d overdue
16235901 MICROSATELLITE INSTABILITY DETECTION SCHULTZHAUS, JANNA NICOLE 5d overdue
17458194 Sample Validation for Cancer Classification SCHLOOP, ALLISON ELIZABETH 3d overdue
16719938 CANCER TISSUE SOURCE OF ORIGIN PREDICTION WITH MULTI-TIER ANALYSIS OF SMALL VARIANTS IN CELL-FREE DNA SAMPLES KALLAL, ROBERT JAMES 6d

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17144021 BITERMINAL DNA FRAGMENT TYPES IN CELL-FREE SAMPLES AND USES THEREOF HAYES, JONATHAN EDWARD 112d overdue
17105175 SYSTEMS AND METHODS FOR EVALUATING LONGITUDINAL BIOLOGICAL FEATURE DATA AUGER, NOAH ANDREW 104d overdue
16721619 CELL-FREE DNA END CHARACTERISTICS MINCHELLA, KAITLYN L 93d overdue
17716395 CELL-FREE DNA METHYLATION AND NUCLEASE-MEDIATED FRAGMENTATION BUCHANAN, BAILEY CHEYENNE 89d overdue
17384251 DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE SALMON, KATHERINE D 84d overdue
17047676 SYSTEMS AND METHODS FOR DETERMINING TUMOR FRACTION IN CELL-FREE NUCLEIC ACID HAYES, JONATHAN EDWARD 19d overdue
15931022 MODEL-BASED FEATURIZATION AND CLASSIFICATION KRIANGCHAIVECH, KETTIP 10d overdue
16235901 MICROSATELLITE INSTABILITY DETECTION SCHULTZHAUS, JANNA NICOLE 5d overdue

Top Art Units

Art UnitApps
1685 6
1682 3
1683 3
1687 1
1686 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18011145 METHYLATED DNA FRAGMENT ENRICHMENT, METHODS, COMPOSITIONS AND KITS SALMON, KATHERINE D 1682 §103 Final Rejection 23d Pending Dec 16, 2022
17968155 DIAGNOSTIC APPLICATIONS USING NUCLEIC ACID FRAGMENTS GUSSOW, ANNE 1683 Other Non-Final OA 5d Pending Oct 18, 2022
17957643 SEQUENCING OF VIRAL DNA FOR PREDICTING DISEASE RELAPSE SCHLOOP, ALLISON ELIZABETH 1683 Other Final Rejection 30d Pending Sep 30, 2022
17817421 SOMATIC VARIANT COOCCURRENCE WITH ABNORMALLY METHYLATED FRAGMENTS KALLAL, ROBERT JAMES 1685 §102 Non-Final OA 28d Pending Aug 04, 2022
17716395 CELL-FREE DNA METHYLATION AND NUCLEASE-MEDIATED FRAGMENTATION BUCHANAN, BAILEY CHEYENNE 1682 §103 Final Rejection 89d overdue Pending Apr 08, 2022
17458194 Sample Validation for Cancer Classification SCHLOOP, ALLISON ELIZABETH 1683 §101 Final Rejection 3d overdue Pending Aug 26, 2021
17384251 DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE SALMON, KATHERINE D 1682 §103 Final Rejection 84d overdue Pending Jul 23, 2021
17144021 BITERMINAL DNA FRAGMENT TYPES IN CELL-FREE SAMPLES AND USES THEREOF HAYES, JONATHAN EDWARD 1685 §101 Non-Final OA 112d overdue Pending Jan 07, 2021
17105175 SYSTEMS AND METHODS FOR EVALUATING LONGITUDINAL BIOLOGICAL FEATURE DATA AUGER, NOAH ANDREW 1687 §101 Final Rejection 104d overdue Pending Nov 25, 2020
17047676 SYSTEMS AND METHODS FOR DETERMINING TUMOR FRACTION IN CELL-FREE NUCLEIC ACID HAYES, JONATHAN EDWARD 1685 §101 Non-Final OA 19d overdue Pending Oct 14, 2020
15931022 MODEL-BASED FEATURIZATION AND CLASSIFICATION KRIANGCHAIVECH, KETTIP 1686 §101 Non-Final OA 10d overdue Pending May 13, 2020
16721619 CELL-FREE DNA END CHARACTERISTICS MINCHELLA, KAITLYN L 1685 Other Non-Final OA 93d overdue Pending Dec 19, 2019
16719938 CANCER TISSUE SOURCE OF ORIGIN PREDICTION WITH MULTI-TIER ANALYSIS OF SMALL VARIANTS IN CELL-FREE DNA SAMPLES KALLAL, ROBERT JAMES 1685 §101 Final Rejection 6d Pending Dec 18, 2019
16235901 MICROSATELLITE INSTABILITY DETECTION SCHULTZHAUS, JANNA NICOLE 1685 §101 Final Rejection 5d overdue Pending Dec 28, 2018

Managing Grail, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month